1887

Abstract

A panel of 10 clinical isolates of herpes simplex virus (HSV) deficient in the expression of thymidine kinase (TK) and phenotypically resistant to aciclovir was characterized. Sequence analysis revealed a variety of mutations in TK (nucleotide substitutions, insertions and deletions), most of which resulted in truncated TK polypeptides. In line with previous reports, the most common mutation was a single G insertion in the ‘G-string’ motif. One HSV-1 isolate and two HSV-2 isolates appeared to encode full-length polypeptides and, in each case, an amino acid substitution likely to be responsible for the phenotype was identified. Pathogenicity was determined using a zosteriform model of HSV infection in BALB/c mice. The majority of isolates appeared to show impaired growth at the inoculation site compared with wild-type virus. They also showed poor replication in the peripheral nervous system and little evidence of zosteriform spread. One exception was isolate 4, which had a double G insertion in the G-string but, nevertheless, exhibited zosteriform spread. These studies confirmed that TK-deficient viruses display a range of neurovirulence with respect to latency and zosteriform spread. These results are discussed in the light of previous experience with TK-deficient viruses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18880-0
2003-06-01
2019-08-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/6/vir841393.html?itemId=/content/journal/jgv/10.1099/vir.0.18880-0&mimeType=html&fmt=ahah

References

  1. Blyth, W. A., Harbour, D. A. & Hill, T. J. ( 1984; ). Pathogenesis of zosteriform spread of herpes simplex virus in the mouse. J Gen Virol 65, 1477–1486.[CrossRef]
    [Google Scholar]
  2. Brown, D. G., Visse, R., Sandhu, G., Davies, A., Rizkallah, P. J., Melitz, C., Summers, W. C. & Sanderson, M. R. ( 1995; ). Crystal structures of the thymidine kinase from herpes simplex virus type-1 in complex with deoxythymidine and ganciclovir. Nat Struct Biol 2, 876–881.[CrossRef]
    [Google Scholar]
  3. Christophers, J., Clayton, J., Craske, J., Ward, R., Collins, P., Trowbridge, M. & Darby, G. ( 1998; ). Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother 42, 868–872.
    [Google Scholar]
  4. Coen, D. M. & Schaffer, P. A. ( 1980; ). Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proc Natl Acad Sci U S A 77, 2265–2269.[CrossRef]
    [Google Scholar]
  5. Coen, D. M., Irmiere, A. F., Jacobson, J. G. & Kerns, K. M. ( 1989; ). Low levels of herpes simplex virus thymidine-thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model. Virology 168, 221–231.[CrossRef]
    [Google Scholar]
  6. Collins, P. & Oliver, N. M. ( 1986; ). Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir. J Antimicrob Chemother 18 (Suppl. B), 103–112.[CrossRef]
    [Google Scholar]
  7. Collins, P. & Darby, G. ( 1991; ). Laboratory studies of herpes simplex virus strains resistant to acyclovir. Rev Med Virol 1, 19–28.[CrossRef]
    [Google Scholar]
  8. Collins, P. & Ellis, M. N. ( 1993; ). Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J Med Virol (Suppl. 1), 58–66.
    [Google Scholar]
  9. Collins, P., Appleyard, G. A. & Oliver, N. M. ( 1982; ). Sensitivity of herpes virus isolates from acyclovir clinical trials. Am J Med 73, 380–382.[CrossRef]
    [Google Scholar]
  10. Darby, G., Larder, B. A. & Inglis, M. M. ( 1986; ). Evidence that the ‘active centre’ of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. J Gen Virol 67, 753–758.[CrossRef]
    [Google Scholar]
  11. Efstathiou, S., Kemp, S., Darby, G. & Minson, A. C. ( 1989; ). The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J Gen Virol 70, 869–879.[CrossRef]
    [Google Scholar]
  12. Erlich, K. S., Mills, J., Chatis, P., Mertz, G. J., Busch, D. F., Follansbee, S. E., Grant, R. M. & Crumpacker, C. S. ( 1989; ). Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med 320, 293–296.[CrossRef]
    [Google Scholar]
  13. Field, H. J. & Wildy, P. ( 1978; ). The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J Hyg 81, 267–277.[CrossRef]
    [Google Scholar]
  14. Field, H. J. & Darby, G. ( 1980; ). Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrob Agents Chemother 17, 209–216.[CrossRef]
    [Google Scholar]
  15. Grey, F., Sowa, M., Collins, P., Fenton, R. J., Harris, W., Snowden, W., Efstathiou, S. & Darby, G. ( 2003; ). Characterization of a neurovirulent acyclovir-resistant variant of herpes simplex virus. J Gen Virol 84, 1403–1410.[CrossRef]
    [Google Scholar]
  16. Hill, T. J., Field, H. J. & Blyth, W. A. ( 1975; ). Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. J Gen Virol 28, 341–353.[CrossRef]
    [Google Scholar]
  17. Hill, E. L., Hunter, G. A. & Ellis, M. N. ( 1991; ). In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 35, 2322–2328.[CrossRef]
    [Google Scholar]
  18. Horsburgh, B. C., Chen, S. H., Hu, A., Mulamba, G. B., Burns, W. H. & Coen, D. M. ( 1998; ). Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: can strain differences compensate for loss of thymidine kinase in pathogenesis? J Infect Dis 178, 618–625.[CrossRef]
    [Google Scholar]
  19. Hwang, C. B., Horsburgh, B. C., Pelosi, E., Roberts, S., Digard, P. & Coen, D. M. ( 1994; ). A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc Natl Acad Sci U S A 91, 5461–5465.[CrossRef]
    [Google Scholar]
  20. Jacobson, J. G., Ruffner, K. L., Kosz-Vnenchak, M., Hwang, C. B., Wobbe, K. K., Knipe, D. M. & Coen, D. M. ( 1993; ). Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia. J Virol 67, 6903–6908.
    [Google Scholar]
  21. Kit, S., Kit, M., Qavi, H., Trkula, D. & Otsuka, H. ( 1983; ). Nucleotide sequence of the herpes simplex virus type 2 (HSV-2) thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide and its comparison with the HSV-1 thymidine kinase gene. Biochim Biophys Acta 741, 158–170.[CrossRef]
    [Google Scholar]
  22. Klemperer, H. G., Haynes, G. R., Shedden, W. I. & Watson, D. H. ( 1967; ). A virus-specific thymidine kinase in BHK-21 cells infected with herpes simplex virus. Virology 31, 120–128.[CrossRef]
    [Google Scholar]
  23. Kost, R. G., Hill, E. L., Tigges, M. & Straus, S. E. ( 1993; ). Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med 329, 1777–1782.[CrossRef]
    [Google Scholar]
  24. Larder, B. A. & Darby, G. ( 1984; ). Virus drug-resistance: mechanisms and consequences. Antiviral Res 4, 1–42.[CrossRef]
    [Google Scholar]
  25. Larder, B. A. & Darby, G. ( 1985; ). Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities. Virology 146, 262–271.[CrossRef]
    [Google Scholar]
  26. Lefkovits, I. & Waldemann, H. ( 1979; ). Limiting Dilution Analysis of Cells in the Immune System. Cambridge: Cambridge University Press.
  27. Nugier, F., Colin, J. N., Aymard, M. & Langlois, M. ( 1992; ). Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey. J Med Virol 36, 1–12.[CrossRef]
    [Google Scholar]
  28. O'Brian, J. J. & Campoli-Richards, D. M. ( 1989; ). Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 37, 233–309.[CrossRef]
    [Google Scholar]
  29. Parris, D. S. & Harrington, J. E. ( 1982; ). Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates. Antimicrob Agents Chemother 22, 71–77.[CrossRef]
    [Google Scholar]
  30. Sakuma, S., Yamamoto, M., Kumano, Y. & Mori, R. ( 1988; ). An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice. Arch Virol 101, 169–182.[CrossRef]
    [Google Scholar]
  31. Sasadeusz, J. J. & Sacks, S. L. ( 1996; ). Spontaneous reactivation of thymidine kinase-deficient, acyclovir-resistant type-2 herpes simplex virus: masked heterogeneity or reversion? J Infect Dis 174, 476–482.[CrossRef]
    [Google Scholar]
  32. Sasadeusz, J. J., Tufaro, F., Safrin, S., Schubert, K., Hubinette, M. M., Cheung, P. K. & Sacks, S. L. ( 1997; ). Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J Virol 71, 3872–3878.
    [Google Scholar]
  33. Sibrack, C. D., McLaren, C. & Barry, D. W. ( 1982; ). Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy. Am J Med 73, 372–375.
    [Google Scholar]
  34. Tenser, R. B. & Dunstan, M. E. ( 1979; ). Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion. Virology 99, 417–422.[CrossRef]
    [Google Scholar]
  35. Tenser, R. B., Ressel, S. & Dunstan, M. E. ( 1981; ). Herpes simplex virus thymidine kinase expression in trigeminal ganglion infection: correlation of enzyme activity with ganglion virus titer and evidence of in vivo complementation. Virology 112, 328–341.[CrossRef]
    [Google Scholar]
  36. Wade, J. C., Newton, B., McLaren, C., Flournoy, N., Keeney, R. E. & Meyers, J. D. ( 1983; ). Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med 96, 265–269.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18880-0
Loading
/content/journal/jgv/10.1099/vir.0.18880-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error